Related Experiment Video
Updated: Jul 7, 2026
09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
[Risk factors for dislypidemia in obese children and adolescents]
Enrique Romero-Velarde1, Octavio Campollo-Rivas, Alfredo Celis de la Rosa
1Instituto de Nutrición Humana, Departamento de Reproduccion Humana, Crecimiento y Desarrollo Infantil. erv205@hotmail.com
Salud Publica De Mexico
|May 25, 2007
Summary
Obesity in children significantly increases the risk of dyslipidemia, characterized by abnormal lipid profiles. This risk is notably higher in females, highlighting a critical health concern.
Area of Science:
- Pediatric Endocrinology
- Cardiovascular Risk Factors
- Metabolic Disorders
Context:
- Childhood obesity is a growing global health issue.
- Dyslipidemia is a major risk factor for cardiovascular disease.
- Early identification of risk factors in children is crucial for long-term health.
Purpose:
- To evaluate the association between obesity and dyslipidemia in children and adolescents.
- To determine the specific lipid profile alterations linked to obesity in this age group.
- To identify demographic factors influencing dyslipidemia risk in obese youth.
Summary:
- A cross-sectional study involving 62 obese and 70 non-obese children (ages 5-15) assessed lipid profiles.
- Obesity was significantly associated with abnormal cholesterol, triglycerides, LDL, and HDL levels (OR 4.47-15.0).
- Multivariate analysis indicated that female gender is an independent risk factor for dyslipidemia in obese children.
Impact:
- Findings underscore the high risk of dyslipidemia in obese children and adolescents.
- Highlights the increased vulnerability of females to obesity-related lipid abnormalities.
- Emphasizes the need for targeted screening and intervention strategies for pediatric obesity and dyslipidemia.
Related Concept Videos
01:18Lipids: Dietary Sources and Requirements
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...